A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom?
Pae
Chi-Un
CU
Marks
David M
DM
Han
Changsu
C
Patkar
Ashwin A
AA
D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology*; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006212:Hallucinations / Q000139:chemically induced* / Q000523:psychology; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011605:Psychoses, Substance-Induced / Q000523:psychology*; D012919:Social Behavior
D000928:Antidepressive Agents; D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole